A nuclear medicine scan may locate prostate cancer recurrence after radical prostatectomy early after disease recurrence and could help guide salvage radiotherapy, according to new research from the University of California Los Angeles (UCLA). The recently published study utilizes PET/CT with gallium-68 prostate-specific membrane antigen (68Ga-PSMA-11) (Calais J et al. 68Ga-PSMA-11 PET/ CT mapping of prostate cancer biochemical recurrence following radical prostatectomy in 270 patients with PSA<1.0ng/ml: Impact on Salvage Radiotherapy Planning. J Nucl Med. 2018 Feb;59(2):230-237. doi: 10.2967/jnumed.117.201749)